145 related articles for article (PubMed ID: 34338304)
21. The Genetics and Biology of FOXL2.
Tucker EJ
Sex Dev; 2022; 16(2-3):184-193. PubMed ID: 34727551
[TBL] [Abstract][Full Text] [Related]
22. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
[TBL] [Abstract][Full Text] [Related]
23. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
Rosario R; Cohen PA; Shelling AN
Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
Cheng JC; Klausen C; Leung PC
PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
[TBL] [Abstract][Full Text] [Related]
26. Molecular assessment of testicular adult granulosa cell tumor demonstrates significant differences when compared to ovarian counterparts.
Siegmund S; Sholl LM; Cornejo KM; Sangoi AR; Otis CN; Mehra R; Hirsch MS; Acosta AM
Mod Pathol; 2022 May; 35(5):697-704. PubMed ID: 34845303
[TBL] [Abstract][Full Text] [Related]
27. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
[TBL] [Abstract][Full Text] [Related]
28. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
[TBL] [Abstract][Full Text] [Related]
29. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
[TBL] [Abstract][Full Text] [Related]
30. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
[TBL] [Abstract][Full Text] [Related]
31. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
[TBL] [Abstract][Full Text] [Related]
32. FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients.
Fokstuen S; Antonarakis SE; Blouin JL
Am J Med Genet A; 2003 Mar; 117A(2):143-6. PubMed ID: 12567411
[TBL] [Abstract][Full Text] [Related]
33. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
[TBL] [Abstract][Full Text] [Related]
34. Mutant FOXL2
Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
[TBL] [Abstract][Full Text] [Related]
35. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
[TBL] [Abstract][Full Text] [Related]
36. FOXL2 impairment in human disease.
Verdin H; De Baere E
Horm Res Paediatr; 2012; 77(1):2-11. PubMed ID: 22248822
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.
Wang WC; Lai YC
J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715
[TBL] [Abstract][Full Text] [Related]
38. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
39. Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci.
Fischer AK; Schömig-Markiefka B; Heydt C; Ratiu D; Mallmann P; Meinel J; Büttner R; Schmidt D; Quaas A
Virchows Arch; 2023 Jul; 483(1):117-124. PubMed ID: 36399188
[TBL] [Abstract][Full Text] [Related]
40. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
